Organo Corporation
Organo Corporation Fundamental Analysis
Organo Corporation (ORGJF) shows moderate financial fundamentals with a PE ratio of 29.49, profit margin of 16.08%, and ROE of 30.43%. The company generates $176.0B in annual revenue with moderate year-over-year growth of 8.59%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 68.2/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze ORGJF's fundamental strength across five key dimensions:
Efficiency Score
ExcellentORGJF demonstrates superior asset utilization.
Valuation Score
ModerateORGJF shows balanced valuation metrics.
Growth Score
ExcellentORGJF delivers strong and consistent growth momentum.
Financial Health Score
ExcellentORGJF maintains a strong and stable balance sheet.
Profitability Score
ModerateORGJF maintains healthy but balanced margins.
Key Financial Metrics
Is ORGJF Expensive or Cheap?
P/E Ratio
ORGJF trades at 29.49 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, ORGJF's PEG of 0.08 indicates potential undervaluation.
Price to Book
The market values Organo Corporation at 6.38 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 20.39 times EBITDA. This signals the market has high growth expectations.
How Well Does ORGJF Make Money?
Net Profit Margin
For every $100 in sales, Organo Corporation keeps $16.08 as profit after all expenses.
Operating Margin
Core operations generate 21.39 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $30.43 in profit for every $100 of shareholder equity.
ROA
Organo Corporation generates $13.65 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Organo Corporation generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Organo Corporation generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
ORGJF converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
29.49
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.08
vs 25 benchmark
P/B Ratio
Price to book value ratio
6.38
vs 25 benchmark
P/S Ratio
Price to sales ratio
4.74
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.24
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.74
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.30
vs 25 benchmark
ROA
Return on assets percentage
0.14
vs 25 benchmark
ROCE
Return on capital employed
0.26
vs 25 benchmark
How ORGJF Stacks Against Its Sector Peers
| Metric | ORGJF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 29.49 | 25.96 | Worse (Expensive) |
| ROE | 30.43% | 1263.00% | Weak |
| Net Margin | 16.08% | -41827.00% (disorted) | Strong |
| Debt/Equity | 0.24 | 0.79 | Strong (Low Leverage) |
| Current Ratio | 2.74 | 10.05 | Strong Liquidity |
| ROA | 13.65% | -1497918.00% (disorted) | Strong |
ORGJF outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Organo Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
68.40%
Industry Style: Cyclical, Value, Infrastructure
High GrowthEPS CAGR
235.67%
Industry Style: Cyclical, Value, Infrastructure
High GrowthFCF CAGR
235.17%
Industry Style: Cyclical, Value, Infrastructure
High Growth